Your browser doesn't support javascript.
loading
Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions.
Jiang, Xing; Ren, Li; Tebon, Peyton; Wang, Canran; Zhou, Xingwu; Qu, Moyuan; Zhu, Jixiang; Ling, Haonan; Zhang, Shiming; Xue, Yumeng; Wu, Qingzhi; Bandaru, Praveen; Lee, Junmin; Kim, Han-Jun; Ahadian, Samad; Ashammakhi, Nureddin; Dokmeci, Mehmet R; Wu, Jinhui; Gu, Zhen; Sun, Wujin; Khademhosseini, Ali.
Afiliação
  • Jiang X; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Ren L; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Tebon P; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Wang C; Key Laboratory for Space Bioscience and Biotechnology, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
  • Zhou X; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Qu M; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Zhu J; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Ling H; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Zhang S; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Xue Y; The Affiliated Hospital of Stomatology, School of Stomatology, Zhejiang University School of Medicine and Key Laboratory of Oral Biomedical Research of Zhejiang Province, Hangzhou, Zhejiang, 310006, China.
  • Wu Q; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Bandaru P; Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
  • Lee J; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Kim HJ; Department of Mechanical and Aerospace Engineering, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Ahadian S; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Ashammakhi N; Department of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong.
  • Dokmeci MR; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Wu J; Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710000, China.
  • Gu Z; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
  • Sun W; State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan, 430070, China.
  • Khademhosseini A; Department of Bioengineering, Center for Minimally Invasive Therapeutics, California Nanosystems Instituste, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Small ; 17(7): e2004282, 2021 02.
Article em En | MEDLINE | ID: mdl-33502118

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Small Assunto da revista: ENGENHARIA BIOMEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Small Assunto da revista: ENGENHARIA BIOMEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos